Ent, splenocytes from acute GVHD mice were analyzed. Flow cytometric analysis

Ent, splenocytes from acute GVHD mice were analyzed. Flow cytometric analysis revealed that the immature B cell portion among B220+ B cells was increased in curcumin reated acute GVHD animals, whereas the mature B cell and memory B cell subsets were decreased (Fig. 5A). Similarly, the proportion of GL-7+CD95+ germinal center B cells was decreased in the curcumin reated group (Fig. 5B). The absolute numbers of B cell subpopulations also showed similar trend (Fig. S4). The mean concentrations of IgG, IgGa and IgG2a, respectively, were decreased in the sera of curcumin-treated animals as compared with those of the vehicletreated group (Fig. 5C).DiscussionCurcumin, which is the orange-yellow component of curry powder, is a natural polyphenol product with anti-inflammatory and anti-cancer properties [24]. There have been various studies that have shown the anti-cancer, anti-viral, and anti-inflammatory properties of the compound [25?7]. This is the first study to investigate the in vivo and in vitro effects of curcumin on the severity of acute GVHD. In vitro, curcumin inhibited alloreactive T cell proliferation and Th1 cell lineage differentiation. In vivo, mice that received curcumin reated splenocytes showed diminished severity scores of acute GVHD, and this inhibition of acute GVHD by curcumin was associated with inhibition of the AP-1 signaling pathway. Surprisingly, transplantation with curcumin reated allogenic splenocytes (allogenic stimulator) resulted in increasedFigure 5. Analysis of B cell subsets in spleens of GVHD mice. C57BL/6 (B6) splenocytes (16107 cells) were incubated with curcumin (10 mM) or vehicle control (DMSO) for 1 h at 37uC before adoptive transfer into lethally irradiated (800 cGy) BALB/c mice. Recipients also received 56106 total bone marrow cells from B6 mice. (A and B) On day 14 after BMT, B cell subsets were analyzed. Splenocytes 370-86-5 chemical information isolated from vehicle or curcumin reated GVHD mice were stained for B220, IgM, and IgD (A) or B220, CD95, and GL-7 (B) and then analyzed by flow cytometry. Cells shown were gated on B220. Numbers indicate the percent of each B cell subtypes in each outlined area. B220+ B cells included IgMhighIgDlow (immature B cells), IgMhighIgDhigh (mature B cells), and IgMlowIgDlow (memory B cells). The proportion of germinal center B cells within B220+ cells in the spleen decreased in the curcumin-treated group (B). The mean concentrations of serum IgG and IgG1 determined by ELISA were lower in curcumin-treated mice as compared with those of the vehicle-treated group (C). Values are showed as mean 6 SEM (n = 3 animals per group). For A and B, one representative experiment of three independent experiments is shown. doi:10.1371/journal.pone.0067171.gTherapeutic Efficacy of Curcumin in Acute GVHDpopulations of CD4+ Treg cells, as well as CD8+ Treg cells in recipient mice, compared to those of mice transplanted with vehicle-treated splenocytes. Along with HLA incompatibility, the intensity of conditioning HDAC-IN-3 manufacturer therapy is known to be a risk factor for the development of acute GVHD [28]. Unfortunately, acute GVHD does develop despite the administration of prophylactic agents, such as calcineurin inhibitors and methotrexate. Upon the occurrence of acute GVHD after HSCT, many patients should take immunosuppressive agents despite the increased risk of severe infection and many other adverse events. Our present study suggests the therapeutic potential of curcumin, which has been used safely for a long time. Althou.Ent, splenocytes from acute GVHD mice were analyzed. Flow cytometric analysis revealed that the immature B cell portion among B220+ B cells was increased in curcumin reated acute GVHD animals, whereas the mature B cell and memory B cell subsets were decreased (Fig. 5A). Similarly, the proportion of GL-7+CD95+ germinal center B cells was decreased in the curcumin reated group (Fig. 5B). The absolute numbers of B cell subpopulations also showed similar trend (Fig. S4). The mean concentrations of IgG, IgGa and IgG2a, respectively, were decreased in the sera of curcumin-treated animals as compared with those of the vehicletreated group (Fig. 5C).DiscussionCurcumin, which is the orange-yellow component of curry powder, is a natural polyphenol product with anti-inflammatory and anti-cancer properties [24]. There have been various studies that have shown the anti-cancer, anti-viral, and anti-inflammatory properties of the compound [25?7]. This is the first study to investigate the in vivo and in vitro effects of curcumin on the severity of acute GVHD. In vitro, curcumin inhibited alloreactive T cell proliferation and Th1 cell lineage differentiation. In vivo, mice that received curcumin reated splenocytes showed diminished severity scores of acute GVHD, and this inhibition of acute GVHD by curcumin was associated with inhibition of the AP-1 signaling pathway. Surprisingly, transplantation with curcumin reated allogenic splenocytes (allogenic stimulator) resulted in increasedFigure 5. Analysis of B cell subsets in spleens of GVHD mice. C57BL/6 (B6) splenocytes (16107 cells) were incubated with curcumin (10 mM) or vehicle control (DMSO) for 1 h at 37uC before adoptive transfer into lethally irradiated (800 cGy) BALB/c mice. Recipients also received 56106 total bone marrow cells from B6 mice. (A and B) On day 14 after BMT, B cell subsets were analyzed. Splenocytes isolated from vehicle or curcumin reated GVHD mice were stained for B220, IgM, and IgD (A) or B220, CD95, and GL-7 (B) and then analyzed by flow cytometry. Cells shown were gated on B220. Numbers indicate the percent of each B cell subtypes in each outlined area. B220+ B cells included IgMhighIgDlow (immature B cells), IgMhighIgDhigh (mature B cells), and IgMlowIgDlow (memory B cells). The proportion of germinal center B cells within B220+ cells in the spleen decreased in the curcumin-treated group (B). The mean concentrations of serum IgG and IgG1 determined by ELISA were lower in curcumin-treated mice as compared with those of the vehicle-treated group (C). Values are showed as mean 6 SEM (n = 3 animals per group). For A and B, one representative experiment of three independent experiments is shown. doi:10.1371/journal.pone.0067171.gTherapeutic Efficacy of Curcumin in Acute GVHDpopulations of CD4+ Treg cells, as well as CD8+ Treg cells in recipient mice, compared to those of mice transplanted with vehicle-treated splenocytes. Along with HLA incompatibility, the intensity of conditioning therapy is known to be a risk factor for the development of acute GVHD [28]. Unfortunately, acute GVHD does develop despite the administration of prophylactic agents, such as calcineurin inhibitors and methotrexate. Upon the occurrence of acute GVHD after HSCT, many patients should take immunosuppressive agents despite the increased risk of severe infection and many other adverse events. Our present study suggests the therapeutic potential of curcumin, which has been used safely for a long time. Althou.